Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. - Wikidata - wikimedia - TriplyDB

Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement.

Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement.

http://www.wikidata.org/entity/Q46269501

about

Radiofrequency catheter ablation of left-sided accessory pathways in children using a new fluoroscopy integrated 3D-mapping system.Voltage gradient mapping and electrophysiologically guided cryoablation in children with AVNRT.Long-term outcome of transvenous pacemaker implantation in infants: a retrospective cohort study.Left ventricular dysfunction is associated with frequent premature ventricular complexes and asymptomatic ventricular tachycardia in children.Treatment of supraventricular tachycardia in infants: Analysis of a large multicenter database.Implantable cardioverter-defibrillators in congenital heart disease Catheter ablation of the anteroseptal accessory pathway from the non-coronary aortic cusp in a pediatric patient.Perinatal arrhythmias.Tachyarrhythmias and catheter ablation in adult congenital heart disease.Genetics of sudden cardiac death in the young.Optimizing outcomes of catheter ablation in infants and toddlers.The Safety and Effectiveness of Flecainide in Children in the Current Era.The blue child - amiodarone-induced blue-gray skin syndrome and pulmonary mass in a child.Pacing and Defibrillators in Complex Congenital Heart Disease.Effects of Triple Cryoenergy Application on Lesion Formation and Coronary Arteries in the Developing Myocardium.Cavotricuspid isthmus ablation and subcutaneous monitoring device implantation in a 2-year-old baby with 2 SCN5A mutations, sinus node dysfunction, atrial flutter recurrences, and drug induced long-QT syndrome: a tricky case of pediatric overlap syn Device therapy in children with and without congenital heart disease.Effectiveness of Radiofrequency Catheter Ablation of Outflow Tract Ventricular Arrhythmias in Children and Adolescents.Efficacy and Safety of Radiofrequency Catheter Ablation of Tachyarrhythmias in 123 Children Under 3 Years of Age.Age-related location of manifest accessory pathway and clinical consequences.Radiofrequency Catheter Ablation of Accessory Atrioventricular Pathways in Infants and Toddlers ≤ 15 kg.Catheter Ablation of Pediatric Focal Atrial Tachycardia: Ten-Year Experience Using Modern Mapping Systems.Catheter ablation of pediatric AV nodal reentrant tachycardia: results in small children.Feasibility and safety of transseptal puncture procedures for radiofrequency catheter ablation in small children weighing below 30 kg: single-centre experience.Stress and cardiac arrhythmias.Supraventricular microreentry in a newborn due to a giant atrial septum aneurysm.Discontinuation of paediatric injectable digoxin: A loss for optimal drug therapy in children.Management of paediatric arrhythmias in Europe.Management of paediatric arrhythmias in Europe: authors' reply.Radiofrequency catheter ablation of atrioventricular nodal reentry tachycardia in children and adolescents: a single center experience.Neonatal arrhythmias: diagnosis, treatment, and clinical outcome.Acute right ventricular resynchronization improves haemodynamics in children after surgical repair of tetralogy of Fallot.Emergency Pacing via the Umbilical Vein and Subsequent Permanent Pacemaker Implantation in a Neonate.Tachykarde Herzrhythmusstörungen bei Kindern ohne angeborene Herzfehler

P2860

Q33168267-0005268B-CB4D-47A7-90DF-F66D987B7D83 Q33168525-FDF7365E-58AD-4A6E-B689-36681552A886 Q33168547-F8FC02A3-9281-4B14-B991-E2A3A5C90DA3 Q33168548-82311875-2D98-48FC-A9B9-BEDF3EB07142 Q35613224-143016BC-51E5-43D5-A957-40A6D03D508C Q36973794-79B577E7-51B8-4733-952E-13F14D2BF4E5 Q37680695-BC144E73-919F-43B8-8F70-8F5B54E26BC8 Q38205187-662BA628-7542-41F5-A811-3D79232F1AF9 Q38208370-63A7728A-7647-47BF-9D0F-D3CB1C3B3A28 Q38259330-136D57CB-DEC4-41DC-91B4-28E0B32C5046 Q38341482-A5D42F41-4A42-464D-A007-9CB13A186879 Q38608802-4404BD03-21F6-4362-803E-770BF4325AD3 Q38685799-26EC2B9D-12BA-4C2C-8F64-D90EA17A4A1B Q38842825-6E53DDDC-024F-426E-9E27-2C32C6103D55 Q39025809-927FC086-BA79-4E7D-B883-4F8DE7629127 Q39107883-533D54E6-15EB-4C03-B967-4550AC0AD138 Q39152372-474A9270-FBFC-4FF8-AE4F-4D967B8E281D Q39453080-3A927896-FCD9-4EAF-A960-93935032BD02 Q39752908-1BE1F1F8-2A95-40F5-BE62-1D2F116163AA Q39804979-7DC61FBE-0F62-4580-A083-48DA9A4392F1 Q39933394-EF8BB4D7-50D7-4DF2-AA84-1D257B1B30F1 Q40354764-06CD5F17-2B67-4BDE-BA4E-E4B7A51DFE13 Q40930851-8471EC3F-7537-4907-95CF-46080C2498A9 Q41020458-1EB38B68-0314-4BED-817D-D210C9971F47 Q42138312-99FCD50C-B51A-48F6-8B7E-7CE996AD4F25 Q42279530-BBC9927A-B005-43F5-A882-14CAA07A016B Q42432191-3A99E972-1E99-438B-9963-A834311753B8 Q43822614-85F24D0A-88F5-49F0-BD6B-0897C180D0C7 Q44810956-2EDAA919-3384-47F0-9373-57EE741AA6A9 Q47099681-CB02BF8C-ACE5-4BFF-A7B8-BBC86B1E3BDD Q47174155-80AB2D61-E740-4485-A746-2E5566B2D9C8 Q52692221-44B0F21D-5D3E-4C09-83D2-3B6CF1FB3331 Q53663319-97266DC7-4EA9-4503-902E-3CE27C8B2F05 Q58869308-6816EEF9-D4C7-400F-83FE-8FA4B8DC8156

P2860

Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement.

http://www.wikidata.org/entity/Q46269501

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Pharmacological and non-pharma ...... oup joint consensus statement.

@en

Pharmacological and non-pharma ...... oup joint consensus statement.

@nl

type

label

Pharmacological and non-pharma ...... oup joint consensus statement.

@en

Pharmacological and non-pharma ...... oup joint consensus statement.

@nl

prefLabel

Pharmacological and non-pharma ...... oup joint consensus statement.

@en

Pharmacological and non-pharma ...... oup joint consensus statement.

@nl

P1433

Q46269501-F0853BC8-EBC5-4B57-8D39-79D7BA909641

P1476

Q46269501-715BAA35-41B8-49CE-8C3B-B8DF6AF66D22

P2093

Q46269501-1A5E54BC-7A42-41B2-A73D-58FFBF994849

Q46269501-30C6AF34-4AF3-4B12-8730-404A19906EDE

Q46269501-42DBCD83-6C7F-40F9-AC7B-644E2CB2CE7B

Q46269501-546B47F7-D07F-4610-9DCF-770437603E1E

Q46269501-62CCF9D5-3CCE-463C-943C-4CC9F534B278

Q46269501-7666F58F-E200-4A23-ABF4-705DC85A3A3C

Q46269501-8CF853DF-9058-493A-90D0-738FD5350F9D

Q46269501-8D4F91C6-60EF-4223-9CAF-1348CF94A062

Q46269501-92844F56-75C8-4998-9B87-8D40FA1273F6

Q46269501-9FA92CCC-004A-4616-8338-DFB51F0FB3E8

P2860

Q46269501-016D06FF-4369-4959-AB72-3AE37BA63319

Q46269501-020BB033-A6FE-43DA-AD99-F97396B7402C

Q46269501-045E4D24-FF18-47AE-9C7F-0361187A5763

Q46269501-04C9937C-33E4-452A-8C7F-CAD361B3DB8E

Q46269501-06D4ECE3-1290-4565-92A9-6B4C11D37930

Q46269501-0875CAD7-D95D-4B50-A7AE-E31CA47EB7CC

Q46269501-08BC9BE1-471F-4BD8-83C2-3BD61519F3EE

Q46269501-0A6CE716-BDF7-4030-9F1E-6D0657647739

Q46269501-0B4243BE-174F-49DA-A6CD-079AD876B16F

Q46269501-0C700625-632C-4260-899F-EEB5A522B12D

P304

Q46269501-A66A37F4-1C3E-4FCB-86E4-0A3CE735E8D1

P31

Q46269501-B3C3A789-D1EF-453E-91F0-88C2395852C4

P356

Q46269501-DB25B0B8-7069-401E-B29C-D612D43E3E81

P433

Q46269501-CB5BFFF3-F08C-47B4-AA30-3C7AF551A149

P478

Q46269501-1603BBE4-4A20-4EFA-93DF-431154EF2C95

P50

Q46269501-2A2CE16B-9203-4B4B-880F-83A2759A383A

Q46269501-8A32F931-016B-4462-AFF8-5C2AE3CC4FF9

Q46269501-F2B59052-7189-40DA-9037-E7BF145A7F91

P577

Q46269501-A8EF9752-7CF4-47BD-B7F0-95B0575F9724

P5875

Q46269501-C2B6482A-9929-46A4-988E-DDF32BB01BF0

P698

Q46269501-A9467B95-47A8-4B32-A4E7-1EC55F770A52

P921

Q46269501-A39D00B3-9729-4195-B6BB-AF0D87A729B2

P356

P1433

P1476

Pharmacological and non-pharma ...... oup joint consensus statement.

@en

P2093

Association for European Paediatric and Congenital Cardiology

http://www.w3.org/2001/XMLSchema#string

Dominic Abrams

http://www.w3.org/2001/XMLSchema#string

Eloi Marijon

http://www.w3.org/2001/XMLSchema#string

Eric Rosenthal

http://www.w3.org/2001/XMLSchema#string

Fabrizio Drago

http://www.w3.org/2001/XMLSchema#string

Georgia Sarquella-Brugada

http://www.w3.org/2001/XMLSchema#string

Jan Janousek

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Pfammatter

http://www.w3.org/2001/XMLSchema#string

Joachim Hebe

http://www.w3.org/2001/XMLSchema#string

John Deanfield

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr and trafficking in long QT syndrome

Cardiac conduction defects associate with mutations in SCN5A

Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death

A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene

Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias

KCNE5 (KCNE1L) variants are novel modulators of Brugada syndrome and idiopathic ventricular fibrillation

Mutation of an A-kinase-anchoring protein causes long-QT syndrome

Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex

Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome

Congenital heart disease caused by mutations in the transcription factor NKX2-5

P304

1337-1382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EUROPACE/EUT082

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Carina Blomström-Lundqvist

Georgia Sarquella-Brugada

European Heart Rhythm Association

P577

2013-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

249320423

http://www.w3.org/2001/XMLSchema#string

P698

23851511

http://www.w3.org/2001/XMLSchema#string

P921